Barber Daniel Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$31,960.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Barber Daniel

According to the SEC Form 4 filings, Barber Daniel, being in a position of

  1. President and CEO at Aquestive Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 313934 shares for $1.33M,
    over all time since 2018-12-10, has bought 6000 shares for $31,960, and sold 405677 shares for $1.88M.

Biography of Barber Daniel

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,326,8358100

Comparison of Insiders on Amount of Buys and Sells

2026-10-15SaleAquestive Therapeutics, Inc.
AQST
President and CEO
25,000
0.0207%
$4.22$105,600-1.48%
2026-09-15SaleAquestive Therapeutics, Inc.
AQST
President and CEO
25,000
0.02%
$4.82$120,488-4.16%
2026-08-17SaleAquestive Therapeutics, Inc.
AQST
President and CEO
25,000
0.02%
$4.29$107,168+8.86%
2026-07-16SaleAquestive Therapeutics, Inc.
AQST
President and CEO
20,369
0.0208%
$4.00$81,509+14.21%
2026-07-15SaleAquestive Therapeutics, Inc.
AQST
President and CEO
4,631
0.0048%
$4.03$18,683+13.16%
2026-06-15SaleAquestive Therapeutics, Inc.
AQST
President and CEO
25,000
0.0248%
$4.16$104,010+2.49%
2026-05-15SaleAquestive Therapeutics, Inc.
AQST
President and CEO
8,257
0.0086%
$4.29$35,413+1.56%
2026-03-10SaleAquestive Therapeutics, Inc.
AQST
President and CEO
180,677
0.177%
$4.17$753,965-0.48%
2025-09-26SaleAquestive Therapeutics, Inc.
AQST
President and CEO
91,343
0.0923%
$6.03$551,191-29.22%
2025-09-19SaleAquestive Therapeutics, Inc.
AQST
President and CEO
400
0.0004%
$6.00$2,400-25.22%
2019-08-27PurchaseAquestive Therapeutics, Inc.
AQST
4,000
0.0166%
$3.99$15,960+14.36%
2018-12-10PurchaseAquestive Therapeutics, Inc.
AQST
2,000
0.0093%
$8.00$16,000-37.05%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.